key: cord-0315905-8u73eqhu
authors: Peter V. Coyle, Naema Hassan Al Molawi; Mohamed Ali Ben Hadj Kacem, Reham Awni El Kahlout; Einas Al Kuwari, Abdullatif Al Khal; Imtiaz Gilliani, Andrew Jeremijenko; Hatoun Saeb, Sheikh Mohammad Al Thani; Roberto Bertollini, Hanan F. Abdul Rahim; Hiam Chemaitelly, Patrick Tang; Ali Nizar Latif, Saad Al Kaabi; Muna A. Rahman S. AlMaslamani, Brendan David Morris; Nasser Al-Ansari, Anvar Hassan Kaleeckal; Raddad, Laith J. Abu
title: Inclusion of cycle threshold (CT) values when reporting SARS-CoV-2 RT-PCR results improves clinical Interpretation in suspected and confirmed COVID-19
date: 2021-02-12
journal: nan
DOI: 10.1101/2021.02.11.21251557
sha: a2568dd906d849735adeb4b488ee081bf76cf425
doc_id: 315905
cord_uid: 8u73eqhu

nan

value is inverse to the viral load, with clearance indicated by rising CTs. This is because more 35 PCR cycles are required to detect the virus. Using CTs in estimating viral load and 36 transmission risk is not routine because of perceived lack of platform to platform 37 concordance and the absence of a direct link between CT values and clinical outcome. 38 A positive result for SARS-CoV-2 is defined by the manufacturer-specified CT values for one 39 or more genes, with an inconclusive result reported where the combination of reactive 40 genes fails to meet the definition. 41 After infection SARS-CoV-2 has a short latent period where virus is undetectable for about 4 42 days, followed by a period of high viral load coinciding with the pre-symptomatic and 43 symptomatic transmission phase, lasting for another four days, and then followed by 44 prolonged viral RNA shedding [3] [4] [5] [6] [7] [8] . The timing of transmission varies with the data source 45 with Ganyani reporting the generation interval (time between infection events in an 46 infector-infectee pair) as 5.20 days (95%: CrL 3.78-6.78) and 3.95 days (95% CrI: 3. 01-4.91) for two separate outbreaks [9] . 48 At the onset of symptoms patients present with high viral loads (<CT 20) which 49 subsequently fall in both upper and lower respiratory tracts, with higher loads in lower 50 airways than those seen in NPS/OPS specimens [10] . Detection of low level viral RNA can 51 last for weeks to months but transmission does not typically exceed 10 days from first PCR 52 or symptom onset in mild infections and 20 days in severe illness [10] [11] [12] . Prolonged 53 shedding and categorical reporting (positive or negative) can risk inferring patients are 54 infectious when they are in recovery, leading often to unnecessary extension of quarantine. 55 Attempts to use CT values as a surrogate of viral load and by extrapolation of disease 56 severity have been reported but not widely adopted. Wishaupt [13] showed low CT values 57 in common respiratory viral infections, including seasonal human coronaviruses (HCoV), 58 were associated with hospitalisation, increased oxygen requirement and longer lengths of 59 hospital stay. Spencer categorised influenza infections on the basis of an arbitrarily set CT 60 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in To meet test demand in Qatar with a population of 2.8 million, three platforms -Roche, 85 Thermo-Fisher and Cepheid, respectively amplifying 2, 3 and 2 gene targets, were used for 86 SARS-CoV-2 RT-PCR. A review of their respective assay performance was undertaken to see 87 whether CT values could be safely added to reporting and improve interpretation of SARS- perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 12, 2021. ; https://doi.org/10.1101/2021.02.11.21251557 doi: medRxiv preprint 

Positive 116213 02/04/2020 -25/08/2020 All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted February 12, 2021. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 12, 2021. ; https://doi.org/10.1101/2021.02.11.21251557 doi: medRxiv preprint perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 12, 2021. ; https://doi.org/10.1101/2021.02.11.21251557 doi: medRxiv preprint preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted February 12, 2021. ; https://doi.org/10.1101/2021.02.11.21251557 doi: medRxiv preprint

In review of patients initially reported with non-positive result (reactive, inconclusive or 200 negative) it was found that a positive (CT≤30) result was reported within 10 days in 5.2%, 201 1.9% and 7.1% of reactive, negative and inconclusive results respectively; acute early 202 infections, defined by a CT<20, were reported in 0.2%, 0.8% and 1.6% of cases - Within 4 days of a negative result a rapid increase in load was seen on day 1 which 207 continued to rise on days 2 and 3 in keeping with the predicted transition from the 208 asymptomatic to a symptomatic phase of infection - Figure 3 [3]. perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted February 12, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Seroprevalence by Reporting Category 216 The respective seroprevalence of patients in the different Reporting Categories when cross-217 referenced against the Seroprevalence database is shown in Figure 4 . There was a trend to 218 higher seroprevalence respectively for negative, single positive RT-PCR, inconclusive, >1 219 positive RT-PCR and reactive. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 12, 2021. ; https://doi.org/10.1101/2021.02.11.21251557 doi: medRxiv preprint provide similar amplification profiles, as demonstrated in Figure The need for and duration of quarantine for patients with a Reactive result was reduced 291 from 14 to 7 days as these patients were deemed suitable for home self-isolation. This new 292 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 12, 2021. ; https://doi.org/10.1101/2021.02.11.21251557 doi: medRxiv preprint policy reduced the numbers in hotel or hospital quarantine and allowed individuals and 293 families a significant financial saving and better well-being by avoiding or reducing the need 294 for hotel quarantine accommodation that was introduced in response to the pandemic.

The policy also supported the country's tracking and tracing application EHTERAZ (meaning perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 12, 2021. ; https://doi.org/10.1101/2021.02.11.21251557 doi: medRxiv preprint perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted February 12, 2021. ; https://doi.org/10. 1101 /2021 

World Health Organization: Timeline of WHO's response to COVID-19

World Health Organization: Laboratory testing of 2019 novel coronavirus

Geneva: World 317 Health Organization

Substantial undocumented 319 infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)

The Incubation Period of Coronavirus Disease

Publicly Reported Confirmed Cases: Estimation and Application

Report of the WHO-China Joint Mission on Coronavirus 326 Disease 2019 (COVID-19

Transmission of 2019-nCoV Infection from an

Pitfalls in 357 interpretation of CT-values of RT-PCR in children with acute respiratory tract 358 infections

Factors associated with real-time RT-PCR cycle 362 threshold values among medically attended influenza episodes

Understanding the true burden and infection dynamics of 365

Centers for Disease Control and Prevention: Duration of Isolation and Precautions 368 for Adults with COVID-19

Interpreting Diagnostic Tests for SARS-CoV-2

Public Health England: Cycle threshold (Ct) in SARS-CoV-2 RT-PCR: A guide for 381 health protection teams about interpreting Ct in real-time, reverse transcription 382 polymerase chain reaction (RT-PCR) assays performed for Sars-CoV-2

Centers for Disease Control and Prevention: Duration of Isolation and Precautions 386 for Adults with COVID-19

Korea Disease Control and Prevention Agency: Findings from investigation and 389 analysis of re-positive cases